Verition Fund Management LLC Tyme Technologies, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$1.76 - $3.73 $264,000 - $559,500
-150,000 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$2.01 - $4.21 $301,499 - $631,500
150,000 New
150,000 $554,000
Q2 2018

Aug 15, 2018
SELL
$2.05 - $4.09 $36,699 - $73,219
-17,902 Closed
0 $0
Q1 2018

May 16, 2018
BUY
$2.12 - $7.0 $37,952 - $125,314
17,902 New
17,902 $40,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email